TITLE

Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review)

AUTHOR(S)
TING ZHANG; XIANGDONG ZHOU
PUB. DATE
April 2014
SOURCE
Experimental & Therapeutic Medicine;2014, Vol. 7 Issue 4, p763
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Airway mucus hypersecretion is a significant clinical and pathological feature of chronic inflammatory airway diseases. Its clinical presentations include recurrent coughing and phlegm. Airway mucus is closely associated with the occurrence, development and prognosis of chronic inflammatory airway diseases and critically affects the lung function, quality of life, hospitalization rate and mortality of patients with chronic inflammatory airway diseases. Therefore, expectorant therapies targeting the potential mechanisms of mucus hypersecretion have been the focus of numerous studies. Conventional expectorants are mainly mucoactive medicines, including nausea-stimulating expectorants, mucolytics, mucokinetics, and proteases and nucleases. In addition, certain traditional Chinese herbal medicines and non-mucoactive agents, including muscarinic acetylcholine receptor antagonists, corticosteroids, leukotriene receptor antagonists and macrolide antibiotics, have also shown expectorant effects. Several novel medicines for expectorant therapy have emerged, including cholesterol-lowering statins, epidermal growth factor receptor tyrosine kinase inhibitors, phosphodiesterase-4 inhibitors, stanozolol, surfactants, flavonoids, tachykinin receptor antagonists, protease inhibitors, cytokine antagonists and purinergic agonists. With the increasing number of multidisciplinary studies, the effectiveness of expectorant therapy for the treatment of chronic inflammatory airway diseases has been confirmed. Therefore, the development of novel expectorants and the standardization of expectorant therapy are the direction and focus of future studies, thus benefiting patients who have a chronic inflammatory airway disease.
ACCESSION #
94754515

 

Related Articles

  • What's the alternative? SINUSITIS. Allardice, Pamela // Australian Women's Weekly;Oct2003, Vol. 73 Issue 10, p219 

    Provides ideas on managing chronic sinusitis. Symptoms of chronic sinusitis; Effectiveness of saltwater in draining mucus; Therapeutic use of herbs and spices to open clogged sinuses.

  • Foreword. Makino, S.; Furusho, K.; Miyamoto, T.; Ohta, K. // International Archives of Allergy & Immunology;2000 Supplement, Vol. 121, p1 

    Provides information on the guidelines released for the treatment and management of asthma in Japan. Concerns regarding asthma as a chronic inflammatory disorder of the airway; Acceptance of Kampo medicine for asthma therapy.

  • Phytotherapy for Lower Respiratory Disease: Basic Principles. Bone, Kerry // Townsend Letter for Doctors & Patients;Nov2005, Issue 268, p100 

    Presents information regarding the traditional herbal strategies for treating lung diseases and the important herbal concepts involved in supporting the innate defenses of the lungs during infection. Discussion of the concepts of expectorants and the scientific investigations into their effect;...

  • 1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis. Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Müller, Janine; Brotzmann, Viktoria; Ebmeyer, Jörg; Kaltschmidt, Barbara; Kaltschmidt, Christian // PLoS ONE;7/24/2015, Vol. 10 Issue 7, p1 

    Inflammatory diseases of the respiratory system such as rhinosinusitis, chronic obstructive pulmonary disease, or bronchial asthma are strongly associated with overproduction and hypersecretion of mucus lining the epithelial airway surface. 1,8-cineol, the active ingredient of the pharmaceutical...

  • Absent Smooth Muscle Actin Immunoreactivity of the Small Bowel Muscularis Propria Circular Layer in Association with Chromosome 15q11 Deletion in Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome. Szigeti, Reka; Chumpitazi, Bruno P.; Finegold, Milton J.; Ranganathan, Sarangarajan; Craigen, William J.; Carter, Beth A.; Tatevian, Nina // Pediatric & Developmental Pathology;Jul/Aug2010, Vol. 13 Issue 4, p322 

    Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS; OMIM%249210) is a rare and severe form of congenital intestinal and urinary dysfunction and malformation. Histologic studies suggest that the predominant intestinal manifestation is smooth muscle myopathy. Molecular observations...

  • In Vitro and In Vivo Characterization of Two C-11-Labeled PET Tracers for Vesicular Acetylcholine Transporter. Padakanti, Prashanth; Zhang, Xiang; Jin, Hongjun; Cui, Jinquan; Wang, Ruike; Li, Junfeng; Flores, Hubert; Parsons, Stanley; Perlmutter, Joel; Tu, Zhude // Molecular Imaging & Biology;Dec2014, Vol. 16 Issue 6, p773 

    Purpose: The vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. Herein, two potent and selective C-labeled VAChT inhibitors were evaluated in rodents and nonhuman primates for imaging VAChT in vivo. Procedures: For both (−)-[C]...

  • Syntheses and Radiosyntheses of Two Carbon-11 Labeled Potent and Selective Radioligands for Imaging Vesicular Acetylcholine Transporter. Padakanti, Prashanth; Zhang, Xiang; Li, Junfeng; Parsons, Stanley; Perlmutter, Joel; Tu, Zhude // Molecular Imaging & Biology;Dec2014, Vol. 16 Issue 6, p765 

    Purpose: The vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. The syntheses and C-11 labeling of two potent enantiopure VAChT inhibitors are reported here. Procedures: Two VAChT inhibitors, (±)- 2 and (±)- 6, were successfully...

  • Autoantibodies to Agrin in Myasthenia Gravis Patients. Zhang, Bin; Shen, Chengyong; Bealmear, Beverly; Ragheb, Samia; Xiong, Wen-Cheng; Lewis, Richard A.; Lisak, Robert P.; Mei, Lin // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    To determine if patients with myasthenia gravis (MG) have antibodies to agrin, a proteoglycan released by motor neurons and is critical for neuromuscular junction (NMJ) formation, we collected serum samples from 93 patients with MG with known status of antibodies to acetylcholine receptor...

  • Pharmacological Benefits of Herbal Formulations in the Management of Psoriasis vulgaris. BOCA, Andreea Nicoleta; TATARU, Alexandru; BUZOIANU, Anca Dana; PINCELLI, Carlo; SOCACIU, Carmen // Notulae Botanicae Horti Agrobotanici Cluj-Napoca;2014, Vol. 42 Issue 1, p1 

    Psoriasis is a chronic inflammatory skin disease, with an important impact on the patient's quality of life. Its incidence and prevalence are continuously increasing. The complex ethiopathology of this disorder is only partially known; there is a clear genetic predisposition, which associates a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics